SION FY 2025 Earnings — Sionna Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SIONSionna Therapeutics, Inc.

$2B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$647,000

Operating Income

-$89M

Net Income

-$75M

EPS (Diluted)

$-1.88

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$67M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$326M

Total Liabilities

$19M

Stockholders' Equity

$307M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$647,000	-$668,000	+3.1%
Operating Income	-$89M	-$71M	-26.1%
Net Income	-$75M	-$62M	-22.0%